Protagenic Therapeutics (PTIX) Short Interest Ratio & Short Volume → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free PTIX Stock Alerts $1.38 -0.18 (-11.50%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Protagenic Therapeutics Short Interest DataCurrent Short Volume9,800 sharesPrevious Short Volume11,300 sharesChange Vs. Previous Month-13.27%Dollar Volume Sold Short$13,693.54Short Interest Ratio / Days to Cover0.9Last Record DateApril 15, 2024Outstanding Shares4,440,000 sharesFloat Size3,550,000 sharesShort Percent of Float0.28%Today's Trading Volume10,467 sharesAverage Trading Volume9,895 sharesToday's Volume Vs. Average106% Short Selling Protagenic Therapeutics ? Sign up to receive the latest short interest report for Protagenic Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPTIX Short Interest Over TimePTIX Days to Cover Over TimePTIX Percentage of Float Shorted Over Time Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 Protagenic Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20249,800 shares $13,693.54 -13.3%0.3%0.9 $1.40 3/31/202411,300 shares $19,775.00 -7.4%0.3%1.1 $1.75 3/15/202412,200 shares $14,030.00 +32.6%0.3%1.3 $1.15 2/29/20249,200 shares $9,660.00 -6.1%0.3%1.1 $1.05 2/15/20249,800 shares $9,457.00 -31.0%0.3%1.4 $0.97 1/31/202414,200 shares $13,490.00 No Change0.4%2.4 $0.95 Get the Latest News and Ratings for PTIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protagenic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/20239,200 shares $7,866.00 -6.1%0.3%0.7 $0.86 10/31/20239,800 shares $7,614.60 +988.9%0.3%0.7 $0.78 10/15/2023900 shares $755.10 -81.6%0.0%0.1 $0.84 9/30/20234,900 shares $9,016.00 +69.0%0.1%0.4 $1.84 9/15/20232,900 shares $5,046.00 +107.1%0.1%0.7 $1.74 8/31/20231,400 shares $2,660.00 +16.7%0.0%0.4 $1.90 2/12/2021100 shares $414.00 No ChangeN/A1 $4.14 1/29/2021100 shares $415.00 No ChangeN/A0.1 $4.15 9/30/2020100 shares $122.00 No ChangeN/A1 $1.22 9/15/2020100 shares $117.00 No ChangeN/A1 $1.17 8/31/2020100 shares $117.00 No ChangeN/A1 $1.17 8/14/2020100 shares $117.00 No ChangeN/A1 $1.17 7/31/2020100 shares $117.00 No ChangeN/A1 $1.17 7/15/2020100 shares $117.00 No ChangeN/A1 $1.17 6/30/2020100 shares $117.00 No ChangeN/A1 $1.17 6/15/2020100 shares $115.00 No ChangeN/A1 $1.15 5/29/2020100 shares $125.00 No ChangeN/A1 $1.25 5/15/2020100 shares $125.00 No ChangeN/A1 $1.25 4/30/2020100 shares $125.00 No ChangeN/A1 $1.25 4/15/2020100 shares $125.00 No ChangeN/A1 $1.25 3/31/2020100 shares $116.00 No ChangeN/A0.5 $1.16 3/13/2020100 shares $162.00 No ChangeN/A1 $1.62 2/28/2020100 shares $141.01 No ChangeN/A1 $1.41 2/14/2020100 shares $141.01 No ChangeN/A1 $1.41 1/31/2020100 shares $141.01 No ChangeN/A1 $1.41 1/15/2020100 shares $141.01 No ChangeN/A1 $1.41 12/31/2019100 shares $380.00 No ChangeN/A1 $3.80 PTIX Short Interest - Frequently Asked Questions What is Protagenic Therapeutics' current short interest? Short interest is the volume of Protagenic Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 9,800 shares of PTIX short. 0.28% of Protagenic Therapeutics' shares are currently sold short. Learn More on Protagenic Therapeutics' current short interest. What is a good short interest ratio for Protagenic Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PTIX shares currently have a short interest ratio of 1.0. Learn More on Protagenic Therapeutics's short interest ratio. What is a good short interest percentage for Protagenic Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.28% of Protagenic Therapeutics' floating shares are currently sold short. Is Protagenic Therapeutics' short interest increasing or decreasing? Protagenic Therapeutics saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 9,800 shares, a decrease of 13.3% from the previous total of 11,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Protagenic Therapeutics' float size? Protagenic Therapeutics currently has issued a total of 4,440,000 shares. Some of Protagenic Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Protagenic Therapeutics currently has a public float of 3,550,000 shares. How does Protagenic Therapeutics' short interest compare to its competitors? 0.28% of Protagenic Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Protagenic Therapeutics: Tenax Therapeutics, Inc. (1.88%), Adial Pharmaceuticals, Inc. (26.72%), Clever Leaves Holdings Inc. (0.61%), Trevena, Inc. (0.33%), Cadrenal Therapeutics, Inc. (2.04%), eFFECTOR Therapeutics, Inc. (7.16%), Kineta, Inc. (1.23%), Pasithea Therapeutics Corp. (1.34%), Enveric Biosciences, Inc. (1.40%), Chemomab Therapeutics Ltd. (1.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Protagenic Therapeutics stock? Short selling PTIX is an investing strategy that aims to generate trading profit from Protagenic Therapeutics as its price is falling. PTIX shares are trading down $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Protagenic Therapeutics? A short squeeze for Protagenic Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PTIX, which in turn drives the price of the stock up even further. How often is Protagenic Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PTIX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: TENX Short Squeeze ADIL Short Squeeze CLVR Short Squeeze TRVN Short Squeeze CVKD Short Squeeze EFTR Short Squeeze KA Short Squeeze KTTA Short Squeeze ENVB Short Squeeze CMMB Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PTIX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry